1. Home
  2. ILMN vs DUOL Comparison

ILMN vs DUOL Comparison

Compare ILMN & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • DUOL
  • Stock Information
  • Founded
  • ILMN 1998
  • DUOL 2011
  • Country
  • ILMN United States
  • DUOL United States
  • Employees
  • ILMN N/A
  • DUOL N/A
  • Industry
  • ILMN Medical Specialities
  • DUOL Computer Software: Prepackaged Software
  • Sector
  • ILMN Health Care
  • DUOL Technology
  • Exchange
  • ILMN Nasdaq
  • DUOL Nasdaq
  • Market Cap
  • ILMN 15.9B
  • DUOL 14.8B
  • IPO Year
  • ILMN 2000
  • DUOL 2021
  • Fundamental
  • Price
  • ILMN $81.09
  • DUOL $526.85
  • Analyst Decision
  • ILMN Buy
  • DUOL Buy
  • Analyst Count
  • ILMN 18
  • DUOL 15
  • Target Price
  • ILMN $127.78
  • DUOL $454.85
  • AVG Volume (30 Days)
  • ILMN 2.4M
  • DUOL 827.8K
  • Earning Date
  • ILMN 05-08-2025
  • DUOL 05-01-2025
  • Dividend Yield
  • ILMN 3.83%
  • DUOL N/A
  • EPS Growth
  • ILMN N/A
  • DUOL 114.70
  • EPS
  • ILMN N/A
  • DUOL 2.04
  • Revenue
  • ILMN $4,337,000,000.00
  • DUOL $811,214,000.00
  • Revenue This Year
  • ILMN N/A
  • DUOL $35.82
  • Revenue Next Year
  • ILMN $3.22
  • DUOL $26.77
  • P/E Ratio
  • ILMN N/A
  • DUOL $258.69
  • Revenue Growth
  • ILMN N/A
  • DUOL 39.15
  • 52 Week Low
  • ILMN $68.70
  • DUOL $145.05
  • 52 Week High
  • ILMN $156.66
  • DUOL $544.93
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 51.02
  • DUOL 69.60
  • Support Level
  • ILMN $78.55
  • DUOL $496.27
  • Resistance Level
  • ILMN $85.90
  • DUOL $531.69
  • Average True Range (ATR)
  • ILMN 2.77
  • DUOL 16.29
  • MACD
  • ILMN 0.19
  • DUOL -6.54
  • Stochastic Oscillator
  • ILMN 42.74
  • DUOL 62.85

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.

Share on Social Networks: